- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 24.06. | Nuvalent chases after Nuvation in ROS1 lung cancer | ||
| 24.06. | AZ, Daiichi get Datroway nod in lung cancer on second try | ||
| 24.06. | ADA: Vertex closer to weaning type 1 diabetics off insulin | ||
| 24.06. | Novo Nordisk's fling with Hims & Hers ends in a bust-up | ||
| 24.06. | Senator says ACIP next meeting should be postponed | ||
| 23.06. | NHS records to be harnessed in pancreatic cancer screening | ||
| 23.06. | EU kicks off review of GSK's linerixibat in PBC | ||
| 23.06. | Roche's Hemlibra follow-up set for phase 3 in haemophilia A | ||
| 23.06. | ADA: Lilly makes its case for oral GLP-1 orforglipron | ||
| 23.06. | ADA: Novo continues effort to rehabilitate CagriSema | ||
| 20.06. | Madrigal closes on EU approval of first MASH treatment | ||
| 20.06. | Grail plans FDA filing for cancer blood test after new trial | ||
| 20.06. | Dupixent is first FDA-approved drug for rare skin disease | ||
| 20.06. | FDA blocks trials that send US cells to 'hostile' countries | ||
| 20.06. | Could a Novo error set up early GLP-1 generics in Canada? | ||
| 19.06. | Dismay but little surprise as NICE rejects Alzheimer's drugs | ||
| 18.06. | Gilead's twice-yearly PrEP drug is cleared by FDA | ||
| 18.06. | Amid sector disruption, biotech must focus on 'fundamentals' | ||
| 18.06. | Biogen bids to extend use of Skyclarys to younger patients | ||
| 18.06. | App to support people with depression launches in GB | ||
| 18.06. | Guidance creates access gap in UK for GPP drug Spevigo | ||
| 18.06. | Fired ACIP panel says RFK Jr is weakening vaccine programmes | ||
| 18.06. | UK regulator overhauls medical device regulation | ||
| 18.06. | Welsh biotech Draig emerges with $140m in financing | ||
| 18.06. | FDA unveils fast-track review path for 'national priorities' |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .